Coronavirus disease 2019 (COVID-19) vaccine doses to be administered this week in UK; President-elect Joe Biden nominates HHS secretary, CDC director; Biotechnology Innovation Organization sues to block new international drug pricing policy.
As the first Western country to issue approval for emergency use of Pfizer and BioNTech’s vaccine against coronavirus disease 2019 (COVID-19), residents of the United Kingdom (UK) will be the first to receive the vaccine, with some doses being administered as early as this week. Reported by NPR, the initial batch of the vaccine arrived in the UK last week and is scheduled to first be given to nursing home residents, health care workers, and people aged 80 and over. The UK government’s initial order of 40 million doses will vaccinate 20 million people.
Reported by Reuters, President-elect Joe Biden has made his selections for 2 public health positions, HHS secretary and CDC director. He has nominated California Attorney General Xavier Becerra and Massachusetts General Hospital's Chief of Infectious Diseases Rochelle Walensky, respectively. The move comes as Biden prepares to take office next month in the midst of record cases of COVID-19 and a daily death toll that has exceeded 2000 in recent days.
Reported by STAT, Biotechnology Innovation Organization (BIO) filed a lawsuit on Friday to block implementation of President Donald Trump’s new international drug pricing policy to lower drug prices. Also known as "most favored nations” policy, this policy was presented last month by the Trump administration, and it would decrease what Medicare pays for 50 injectable drugs to the lowest price paid in countries like Japan and Belgium. The move is said to potentially cut reimbursement for some of the best-selling drugs in the United States by half or more.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen